Internal Medicine, Pulmonary Disease · Carmel, NY
NPI
1659334605
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
672 Stoneleigh Ave
Carmel, NY, 10512
Phone (845) 279-7779
Groups this clinician bills Medicare through
Medicare paid, 2024
$248K
4,271 services
Medicare patients, 2024
881
Average age 75
Drug cost, 2024
$2.6M
3,516 prescriptions
Company payments, 2025
$171
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Asaf Savir was code 99214 (office e&m - established), 1,021 times for 543 patients. In total Asaf Savir billed 4,271 services in 59 codes, and Medicare paid $248K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,021 | 543 | $99.30 | $101K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 942 | 496 | $13.51 | $13K |
| 99213 Office E&M - Established | Office | 394 | 316 | $70.22 | $28K |
| 94729 Pulmonary Function Testing | Office | 201 | 196 | $46.02 | $9,250 |
| 94060 Pulmonary Function Testing | Office | 199 | 194 | $33.13 | $6,593 |
| 94727 Pulmonary Function Testing | Office | 199 | 194 | $36.84 | $7,332 |
| 99215 Office E&M - Established | Office | 160 | 117 | $143.77 | $23K |
| 94010 Pulmonary Function Testing | Office | 147 | 134 | $23.25 | $3,417 |
| 99204 Office E&M - New | Office | 142 | 141 | $123.01 | $17K |
| 99232 Hospital E&M - Subsequent | Facility | 139 | 49 | $65.31 | $9,079 |
| G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 129 | 129 | $29.02 | $3,743 |
| 95012 Pulmonary | Office | 118 | 106 | $16.18 | $1,910 |
| 36415 Venipuncture Blood Collection | Office | 92 | 73 | $8.64 | $795 |
| 99233 Hospital E&M - Subsequent | Facility | 53 | 21 | $98.43 | $5,217 |
| 85025 Blood Count | Office | 48 | 39 | $7.61 | $365 |
By year: 2022 $236K for 3,237 services; 2023 $244K for 3,113 services; 2024 $248K for 4,271 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 92 | 73 | $8.64 | $795 |
| 85025 Blood Count | 48 | 39 | $7.61 | $365 |
| 80053 Clinical Chemistry | 35 | 31 | $10.35 | $362 |
| 85379 Clinical Chemistry | 23 | 23 | $9.98 | $230 |
| 83880 Clinical Chemistry | 16 | 16 | $38.47 | $616 |
Medicare prescription drug claims, 2024
In 2024, the drug Asaf Savir prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 688 prescriptions and refills. In total Asaf Savir wrote 3,516 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 688 | 1,377 | 185 | $853K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 456 | 788 | 240 | $23K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 312 | 661 | 91 | $301K |
| Breo Ellipta Fluticasone/Vilanterol | 298 | 606 | 85 | $235K |
| Prednisone Generic | 238 | 272 | 142 | $1,022 |
| Arnuity Ellipta Fluticasone Furoate | 136 | 276 | 45 | $60K |
| Incruse Ellipta Umeclidinium Bromide | 112 | 305 | 35 | $103K |
| Azithromycin Generic | 96 | 115 | 71 | $709 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 94 | 213 | 35 | $21K |
| Spiriva Respimat Tiotropium Bromide | 86 | 200 | 28 | $100K |
| Fluticasone Propionate Generic | 68 | 124 | 43 | $1,190 |
| Montelukast Sodium Generic | 66 | 196 | 24 | $909 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 57 | 107 | 18 | $16K |
| Ventolin Hfa Albuterol Sulfate | 56 | 105 | 29 | $7,575 |
| Symbicort Budesonide/Formoterol Fumarate | 56 | 127 | 23 | $27K |
Brand drugs: 2,425 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Asaf Savir $171 ($171 in general payments such as food, travel and fees) from 1 company. The largest payer was Ceribell, Inc. with $171.
| Company | Payments | Amount |
|---|---|---|
| Ceribell, Inc. CBLL | 1 | $171 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.